Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
03/2007
03/08/2007WO2007026097A1 Novel indole compounds
03/08/2007WO2007025901A1 Diaminopyrimidines as p2x3 and p2x2/3 modulators
03/08/2007WO2007025709A2 Organic compounds
03/08/2007WO2006067392A3 Indole derivatives for the treatment of tuberculosis
03/08/2007US20070055064 Process for the crystallisation of guandinium salts
03/08/2007US20070054948 Purification of olmesartan medoxomil
03/08/2007US20070054923 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
03/08/2007US20070054922 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
03/08/2007US20070054920 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
03/08/2007US20070054917 Piperazine derivates and their use for the treatment of neurological and psychiatric diseases
03/08/2007US20070054910 Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
03/08/2007US20070054900 4-Phenlthiazole and 4-phenylimidizole derivatives and their use as medicaments for the treatment of neurodegenerative diseases, pain and epilepsy
03/08/2007US20070054898 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
03/08/2007US20070054895 e.g. 5-Benzyloxy-2-(4-benzyloxy-phenyl)-3-methyl-1H-indole or salts for treating colon cancer
03/08/2007US20070054892 Isoquinoline potassium channel inhibitors
03/08/2007US20070054891 e.g. 3-(2,4,4'-trichlorobenzhydryloxy)-N-(tert-butyl)azetidine-1-carboxamide; cannabinoid receptor antagonist; antidiabetic agent, antidepressant; eating disorders, obesity, nicotine addiction
03/08/2007CA2822094A1 Isoindole-imide compounds and compositions comprising and methods of using the same
03/08/2007CA2620894A1 Novel benzopyran derivatives as potassium channel openers
03/08/2007CA2620846A1 Benzopyran and pyranopyridine derivatives as potassium channel openers
03/08/2007CA2620658A1 Novel indole compounds
03/08/2007CA2620222A1 Organic compounds
03/08/2007CA2620129A1 Diaminopyrimidines as p2x3 and p2x2/3 modulators
03/08/2007CA2620085A1 Isoindole-imide compounds and compositions comprising and methods of using the same
03/08/2007CA2619450A1 6-n-linked heterocycle-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
03/07/2007EP1758892A1 Compounds and compositions as protein kinase inhibitors
03/07/2007EP1758891A2 Benzimidazolone carboxylic acid derivatives
03/07/2007EP1758884A2 N-cyclic sulfonamido inhibitors of gamma secretase
03/07/2007EP1758883A1 Substituted 2-quinolyl-oxazoles useful as pde4 inhibitors
03/07/2007EP1758882A1 Amido compounds and their use as pharmaceuticals
03/07/2007EP1758864A1 Substituted tetrahydro-2h-isoquinolin-1-one derivatives, method for the production thereof, and use of the same as medicaments
03/07/2007EP1758857A1 Indole derivatives as antiviral agents
03/07/2007EP1442025B1 Pyrimidinones as melanin concentrating hormone receptor 1
03/07/2007EP1440066B1 Pyrazolyl-substituted heterocycles and their use as phytosanitary products
03/07/2007EP0959076B1 Heteroarylperidines and piperazines and their use as antipsychotics and analgetics
03/07/2007CN1926136A Amino cyclopropane carboxamide derivatives as bradykinin antagonists
03/07/2007CN1926133A Epothilone derivatives
03/07/2007CN1926132A Pyrazole compounds useful as protein kinase inhibitors
03/07/2007CN1926129A Novel insecticides
03/07/2007CN1926117A 6-amino-5-cyano-pyrimidine-4-ones used for improving perception, power of concentration, learning efficiency, and/or memory power
03/07/2007CN1926108A Non-nucleotide reverse transcriptase inhibitors
03/07/2007CN1926104A Bicyclic substituted indole-derivative steroid hormone nuclear receptor modulators
03/07/2007CN1923838A Propiconazol metal complex, preparation method and use thereof
03/07/2007CN1923820A Novel carboxylic acid derivatives, their preparation and use
03/07/2007CN1923812A New compounds
03/07/2007CN1303067C Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases
03/07/2007CN1303066C 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
03/07/2007CN1303064C Novel colour former and recording material
03/07/2007CN1303063C Diamine derivative, process for producing the same, and bactericide containing the same as active ingredient
03/06/2007US7186849 C7 ester substituted taxanes
03/06/2007US7186848 Useful pharmaceutical intermediates which can be used in the preparation of the hydroxymethyl-glutaryl coenzyme (HMG-COA) reducing enzyme inhibitor having the INN (International Non-proprietory Name) atorvastatin
03/06/2007US7186843 Aminomethylpyrrolidine derivatives having aromatic substituents
03/06/2007US7186841 Antiinflammation agents
03/06/2007US7186833 Such as 4-(4-hydroxyphenyl)butylamidino-3,5-diamino-6-chloropyrazinecarboxamide hydrochloride; time-release agents; for therapy of chronic bronchitis, emphysema, cystic fibrosis, and eye disorders
03/06/2007US7186746 Indoles having anti-diabetic activity
03/06/2007US7186743 drugs such as 1 -[4-(aminosulfonyl)phenyl]-8-{[(trifluoromethyl)sulfonyl]amino}-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide, used as antiinflammatory agents, antiarthritic agents, antipyretics or analgesics
03/06/2007US7186742 Benzamide inhibitors of the P2X7 receptor
03/06/2007US7186734 Binding to antagonist or inverse antagonist as antiinflammatory agentsand immunological disorders
03/06/2007US7186733 4-(phenyl-(piperidin-4yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
03/06/2007US7186731 2-cyanopyrrolidinecarboxamide compound
03/06/2007US7186724 central nervous system disorders; psychological disorders; Parkinson's disease; Huntington's disease ; sleep disorders
03/06/2007US7186719 Antibacterial agents
03/06/2007US7186718 For therapy of autoimmune, inflammatory, proliferative and hyperproliferative diseases and immunologically-mediated diseases including rejection of transplanted organs or tissues and Acquired Immunodeficiency Syndrome (AIDS
03/06/2007US7186715 Piperazine- and piperidine-derivatives as melanocortin receptor agonists
03/06/2007US7186710 PDE4/7 inhibitors useful in treatment of airway disorders, autoimmune system disorders, skin disorders, arthritis, nerve system disorders
03/06/2007US7186709 Subjecting a vinyl ethers and an unsaturated ketoester to suitable conditions to generate a scaffold having the core dihydropyrancarboxamide or dihydropyrancarboxylic ester or acid; anticarcinogenic agents
03/01/2007WO2007024680A1 Pyrazolopyridine and pyrazolopyrimidine compounds useful as kinase enzymes modulators
03/01/2007WO2007023186A1 Pyrazine derivatives and use as pi3k inhibitors
03/01/2007WO2007022947A2 5-ring heteroaromatic compounds and their use as binding partners for 5-ht5 receptors
03/01/2007WO2007022938A2 Compounds
03/01/2007WO2007003961A3 Gpcr agonists
03/01/2007WO2006124511A3 Stilbene derivatives and methods of inhibiting cancer cell growth and microbial growth
03/01/2007WO2006036994A3 Modulators of crth2, cox-2 and faah
03/01/2007WO2005117882A9 Hydroxamic acid derivatives as metalloprotease inhibitors
03/01/2007WO2005117876A8 Dual small molecule inhibitors of cancer and angiogenesis
03/01/2007US20070049756 Alfuzosin hydrochloride polymorphs
03/01/2007US20070049755 Novel triazolo pyrimidine compounds
03/01/2007US20070049623 1-(Hetero)aryl- and 3-substituted with a group containing an arylaldehyde oxime, e.g., 4-[5-(2-oxo-3-pyridin-4-yl-imidazolidin-1-yl)-pentyloxy]-benzaldehyde O-methyl-oxime; treating enteroviral infections
03/01/2007US20070049621 6-Alkylamino-2-methyl-2'-(N-methyl substituted sulfonamido)methyl-2H-1-benzopyran derivative as anti-inflammatory inhibitor
03/01/2007US20070049605 5H-Dibenzo[c,g]chromene-3,9-diol; estrogen receptor modulators; osteoporosis
03/01/2007US20070049601 BENZOFURAN INHIBITORS OF FACTOR VIIa
03/01/2007US20070049584 Antiinflammatory agents, antidepressants, analgesics, purinergic receptor antagonists; neurodegenerative diseases, spinal cord injuries; 1-(2,3-dichlorophenyl)-N-[(2-methylphenyl)methyl]-1H-tetraazol-5-amine
03/01/2007US20070049570 Quinoline derivatives as phosphodiesterase inhibitors
03/01/2007US20070049558 New Spirotricyclic Derivatives and Their Use as Phosphodiesterase-7 Inhibitors
03/01/2007CA2619365A1 Pyrazolopyridine and pyrazolopyrimidine compounds useful as kinase enzymes modulators
03/01/2007CA2618479A1 Pyrazine derivatives and use as pi3k inhibitors
02/2007
02/28/2007EP1757599A1 Indole derivatives having piperidine rings
02/28/2007EP1757591A1 Cinnamide compound
02/28/2007EP1757590A1 Piperazinylalkylpyrazole derivatives useful as selective T-type calcium channel blockers and preparation method thereof
02/28/2007EP1757582A1 Arylalkylamines and process for production thereof
02/28/2007EP1756109A1 Novel indole derivatives as selective androgen receptor modulators (sarms)
02/28/2007EP1756091A1 Non nucleoside reverse transcriptase inhibitors
02/28/2007EP1756089A1 Mercaptoimidazoles as ccr2 receptor antagonists
02/28/2007EP1756087A1 Amino-5,5-diphenylimidazolone derivatives for the inhibition of beta-secretase
02/28/2007EP1756084A2 Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
02/28/2007EP1756064A2 Pyrazole derivatives, compositions containing such compounds and methods of use
02/28/2007EP1756063A1 Amido compounds and their use as pharmaceuticals
02/28/2007EP1756061A1 Therapeutic compounds: pyridine n oxide scaffold
02/28/2007EP1756060A1 Therapeutic compounds: pyridine as scaffold
02/28/2007EP1756050A1 Aminomethyl-azacycle derivatives as inhibitors of monoamine uptake
02/28/2007EP1626962B1 Benzamide inhibitors of the p2x7 receptor